According to Zhitong Finance App, Changfeng Pharmaceutical (02652.HK) issued an announcement. On July 31, 2026, the company appointed placement agents to induce no less than 6 undertakers to subscribe for 21.7477 million new H shares at an placement price of HK$13.82 per H share in accordance with the terms and conditions of the placement agreement. Placed shares are equivalent to about 7.23% of the issued H shares and about 5.30% of the total number of issued shares, and about 6.74% of the issued H shares and about 5.03% of the total number of issued shares expanded due to the allocation and issuance of the placed shares.

According to Zhitong Finance App, Changfeng Pharmaceutical (02652.HK) issued an announcement. On July 31, 2026, the company appointed placement agents to induce no less than 6 undertakers to subscribe for 21.7477 million new H shares at an placement price of HK$13.82 per H share in accordance with the terms and conditions of the placement agreement. Placed shares are equivalent to about 7.23% of the issued H shares and about 5.30% of the total number of issued shares, and about 6.74% of the issued H shares and about 5.03% of the total number of issued shares expanded due to the allocation and issuance of the placed shares.